ND Capital, founded in 2002, is a venture capital fund investing in life, physical, and data sciences. They focus on Series A and Series C funding, with check sizes tailored to each investment. Their portfolio includes Notify Therapeutics, Vandria, and H55. Operating across the United States and Europe, with teams in Silicon Valley, Switzerland, and the Cayman Islands, ND Capital helps companies bridge markets to secure capital, talent, and business partners.
